G9a induces the epigenetic silencing of the tumor suppressor retinoic acid receptor responder protein 3, and increased G9a expression is associated with HCC progression and poor pathological features, such as vascular invasion, tumor microsatellites, and absence of tumor encapsulation [58]. The gene discussed is EHMT2; the disease is neoplasm.